Intuitive
Medical devices (robotic-assisted surgery) · United States
Intuitive makes the da Vinci surgical robots and the Ion lung-biopsy robot, placing them in hospitals through sales and leases and then earning most of its money from the instruments, accessories and service used in every procedure.
What makes it different
Surgeons run over 10,000 operations a day on its robots.
> 10,000Procedures per dayQ3 2026
Each of those procedures uses Intuitive instruments, the part of the business that repeats.
How big it is
How big is Intuitive?
$10.1BTotal revenueFY2025
3.15MDa Vinci proceduresFY2025
17,021EmployeesFY2025
How it makes money FY2025
Instruments earn more than the robots.
- Instruments and accessories60%$6.0B
- Systems25%$2.5B
- Services16%$1.6B
How the business works
Place robots. Train surgeons. Sell instruments.
- 1da Vinci and Ion robots
- 2Surgeons and OR teams
- 3Instruments for every procedure
Instruments, service and leases make up 84% of revenue, so income follows how often surgeons operate.
Who owns it
- The Vanguard Group9.5%
- BlackRock, Inc.8.6%
CEO: David J. Rosa
Who it competes with
Key moments
- 1995Intuitive Surgical is founded
- 2000FDA clears da Vinci for general laparoscopic surgery
- 2019Ion robotic lung biopsy system launches
- 2024FDA clears da Vinci 5
- 2025Revenue passes $10 billion
Sources
Every number on this page comes from Intuitive's own reports.
Full profile
The rest of the story is in the app.
What Intuitive tracks19 metrics
Da Vinci procedures
Da Vinci installed base
Da Vinci systems placed
Results, quarter by quarterwith a chart
Revenue
Profit
Margin
Where the money comes from2 regions
United States
Outside the U.S.
The full timeline12 moments
2016
2023
2026
Intuitive vs Johnson & Johnsonside by side
Revenue
Profit
People
Point your phone at a logo.
See the company behind it.
The full story in 12 chapters · compare any two companies · 335 companies, and any other on request.
Download on the App Store
